Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Genet Epidemiol. 2009 Apr;33(3):183–197. doi: 10.1002/gepi.20364

TABLE I.

Information of the HapMap chromosomal regions studied and hypothetical disease-causing SNP used for simulations.

Chr. Spanning (base pair) No. of
SNPs
LD of adjacent loci
mean (range)
LD of all pairs of loci
mean (range)
Average
prevalencea
(%)
Causal allele
frequency
D′ r2 D′ r2
1 85.0 kb (75,996,416–76,081,443) 8 0.99 (0.90–1.00) 0.25 (0.04–0.76) 0.91 (0.11–1.00) 0.27 (0.002–0.86) 6.30 (3.68–8.17) 0.28 (0.08–0.38)
2 74.7 kb (165,005,914–165,080,660) 4 1.00 (1.00–1.00) 0.31 (0.02–0.88) 0.77 (0.31–1.00) 0.19 (0.02–0.88) 4.31 (4.00–4.62) 0.14 (0.12–0.17)
3 70.0 kb (48,181,106–48,251,081) 4 1.00 (1.00–1.00) 0.08 (0.02–0.19) 1.00 (1.00–1.00) 0.22 (0.02–0.86) 5.67 (3.45–7.02) 0.25 (0.06–0.34)
4 97.8 kb (95,656,914–95,754,677) 4 0.82 (0.45–1.00) 0.39 (0.09–0.95) 0.82 (0.45–1.00) 0.29 (0.07–0.95) 6.12 (4.85–7.79) 0.26 (0.18–0.38)
5 67.8 kb (86,285,103–86,352,855) 8 0.99 (0.91–1.00) 0.23 (0.02–0.65) 0.97 (0.49–1.00) 0.25 (0.02–0.94) 5.37 (3.91–8.79) 0.21 (0.09–0.43)
6 24.5 kb (85,437,983–85,462,480) 4 1.00 (1.00–1.00) 0.32 (0.02–0.90) 1.00 (1.00–1.00) 0.17 (0.01–0.90) 4.17 (3.68–5.23) 0.11 (0.08–0.18)
7 75.9 kb (79,276,107–79,352,038) 4 1.00 (1.00–1.00) 0.67 (0.48–0.90) 0.93 (0.68–1.00) 0.55 (0.31–0.90) 4.09 (3.68–4.70) 0.12 (0.08–0.18)
8 24.2 kb (73,087,988–73,112,209) 4 1.00 (1.00–1.00) 0.04 (0.02–0.09) 0.99 (0.92–1.00) 0.13 (0.02–0.54) 4.70 (3.99–5.79) 0.17 (0.10–0.28)
9 42.1 kb (69,172,556–69,214,705) 4 0.98 (0.94–1.00) 0.40 (0.01–0.69) 0.99 (0.94–1.00) 0.28 (0.01–0.69) 4.65 (3.53–5.85) 0.15 (0.07–0.23)
10 32.9 kb (67,662,628–67,695,506) 4 0.97 (0.90–1.00) 0.10 (0.04–0.21) 0.93 (0.73–1.00) 0.28 (0.04–0.88) 5.81 (4.54–8.55) 0.23 (0.14–0.39)
17 68.2 kb (40,248,321–40,316,535) 25, 8 0.97 (0.23–1.00) 0.22 (0.003–1.00) 0.94 (0.17–1.00) 0.20 (0.002–1.00) 5.35 (3.84–7.87) 0.22 (0.10–0.39)
22 70.5 kb (33,606,466–33,676,951) 8 1.00 (1.00–1.00) 0.04 (0.004–0.15) 0.84 (0.12–1.00) 0.08 (0.001–0.67) 4.86 (3.37–9.10) 0.17 (0.05–0.45)
The total number of simulation scenarios 89
a

The prevalence was calculated under a disease model representing Alzheimer's disease. In the parentheses, we list the minimum and the maximum prevalence when each SNP in turn was considered the causal locus. In real data (population of Kuopio, eastern Finland, 980 people aged 69–78), the prevalence of Alzheimer's disease was 4.7% [Kuusisto et al., 1994]. SNP, single-nucleotide polymorphism, LD, linkage disequilibrium.